ArticleACS medicinal chemistry letters2025
Novel Non-Hallucinogenic Compounds as 5‑HT2A Agonists for Treating Mental Health Disorders, Namely Depression, Anxiety, Stress Disorders, and Eating Disorders.
Ram W SabnisPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.